RT
Healthcare & Life Sciences
Revier Therapeutics
Germanyrevier.bio
Revier Therapeutics is a Healthcare & Life Sciences startup based in Germany, most recent round Seed, 1 tracked investor.
Activeseed
seed
Stage
1
Investors
About Revier Therapeutics
Revier Therapeutics is a company headquartered in Germany. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Revier Therapeutics develops orally available small molecule inhibitors that selectively target class IIa HDAC enzymes to treat cardiometabolic diseases such as heart failure with preserved ejection fraction (HFpEF) and atherosclerotic cardiovascular disease (ASCVD).
Explore Revier Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.